Page 35«..1020..34353637..4050..»

Category Archives: MS Treatment

Questions of Bias in Covid-19 Treatment Add to the Mourning for Black Families – The New York Times

Posted: Published on May 13th, 2020

Long dissatisfied with the doctor treating his diabetes, Reginald Relf decided to fight through whatever was causing his nagging cough. But then his temperature spiked and his breathing became so labored that he reluctantly took his sisters advice to visit a doctor. The staff at an urgent care clinic in suburban Chicago sent him home, without testing him for Covid-19 but after advising him to quarantine Continue reading

Posted in MS Treatment | Comments Off on Questions of Bias in Covid-19 Treatment Add to the Mourning for Black Families – The New York Times

BioAegis says its ‘inflammation regulator’ is best weapon to fight Covid-19 – CNBC

Posted: Published on May 13th, 2020

An engineer shows a plastic model of the Covid-19 coronavirus at the Quality Control Laboratory at the Sinovac Biotech facilities in Beijing. Nicolas Asfouri | AFP | Getty Images For one little-known biotech company in New Jersey BioAegis Therapeutics Covid-19 may just be the catalyst that will push its breakthrough discovery, plasma gelsolin, to the forefront as a lifesaving treatment for infectious, inflammatory and degenerative diseases. Continue reading

Posted in MS Treatment | Comments Off on BioAegis says its ‘inflammation regulator’ is best weapon to fight Covid-19 – CNBC

He Was a Science Star. Then He Promoted a Questionable Cure for Covid-19. – The New York Times

Posted: Published on May 13th, 2020

When diagnosing the ills afflicting modern science, an entertainment that, along with the disparagement of his critics and fellow researchers, he counts among his great delights, the eminent French microbiologist Didier Raoult will lightly stroke his beard, lean back in his seat and, with a thin but unmistakable smile, declare the poor patient to be stricken with pride. Raoult, who has achieved international fame since his proposed treatment for Covid-19 was touted as a miracle cure by President Trump, believes that his colleagues fail to see that their ideas are the products of mere intellectual fashions that they are hypnotized by methodology into believing that they understand what they do not and that they lack the discipline of mind that would permit them to comprehend their error. Continue reading

Posted in MS Treatment | Comments Off on He Was a Science Star. Then He Promoted a Questionable Cure for Covid-19. – The New York Times

Coronavirus pandemic: From plasma therapy to Favipiravir, here’s a list of treatments and antidotes for COVID-19 so far – Moneycontrol

Posted: Published on May 13th, 2020

The novel coronavirus continues to be on a rampage across the globe, having affected at least 4 million people and taken the lives of at least 280,000. What makes this virus dangerous is its novelty and how little is known about it to scientists, who are carrying out extensive research to study the virus and how to kill it Continue reading

Posted in MS Treatment | Comments Off on Coronavirus pandemic: From plasma therapy to Favipiravir, here’s a list of treatments and antidotes for COVID-19 so far – Moneycontrol

WHO: Some coronavirus treatments show signs of limiting disease’s severity, length | TheHill – The Hill

Posted: Published on May 13th, 2020

The World Health Organization said Tuesday that some treatments have shown promise in limiting the severity and length of coronavirus cases, and that it is prioritizing a handful that show particular signs of promise. We do have some treatments that seem to be in very early studies limiting the severity or the length of the illness but we do not have anything that can kill or stop the virus, spokeswoman Margaret Harris said in a briefing Tuesday, Reuters reported. Continue reading

Posted in MS Treatment | Comments Off on WHO: Some coronavirus treatments show signs of limiting disease’s severity, length | TheHill – The Hill

Rituximab May Be More Effective in Early-Onset Myasthenia Gravis – Neurology Times

Posted: Published on May 13th, 2020

Data from a study of patients with myasthenia gravis who were exposed to rituximab at various points in the disease course, along with a control group, suggest that the anti-CD20 antibody performs better if initiated earlier after the onset of generalized symptoms. Continue reading

Posted in MS Treatment | Comments Off on Rituximab May Be More Effective in Early-Onset Myasthenia Gravis – Neurology Times

Joliet hospital to use new 3-drug treatment for COVID-19, can’t obtain remdesivir at this time – MyWebTimes.com

Posted: Published on May 13th, 2020

As a public service, Morris Hospital & Shaw Media have partnered to provide open access to information related to the COVID-19 (Coronavirus) emergency. Sign up for the newsletter here AMITA Health Saint Joseph Medical Center in Joliet has already ordered the medicines for a new triple drug therapy for patients hospitalized with COVID-19. The wait to receive these drugs shouldn't be long either. Continue reading

Posted in MS Treatment | Comments Off on Joliet hospital to use new 3-drug treatment for COVID-19, can’t obtain remdesivir at this time – MyWebTimes.com

Top Health Experts Paint Bleak Picture of Pandemic – The New York Times

Posted: Published on May 13th, 2020

[singing] Singing: Oh, brother, I want you to keep on marchin. Continue reading

Posted in MS Treatment | Comments Off on Top Health Experts Paint Bleak Picture of Pandemic – The New York Times

From Treating Virus To Catching It Herself: Kerala Nurse Back To Work – NDTV

Posted: Published on May 13th, 2020

The nurse was shifted from ICU duty to the COVID-19 ward as the cases increased. Continue reading

Posted in MS Treatment | Comments Off on From Treating Virus To Catching It Herself: Kerala Nurse Back To Work – NDTV

Vanda Pharmaceuticals Announces Agreement with FDA on Resubmission of the Application for HETLIOZ for the Treatment of Patients with Smith-Magenis…

Posted: Published on May 13th, 2020

WASHINGTON, May 13, 2020 /PRNewswire/ --Vanda Pharmaceuticals, Inc. Inc. (Vanda) (Nasdaq: VNDA) today announced that following the completion of a Type A Meeting with the U.S. Continue reading

Posted in MS Treatment | Comments Off on Vanda Pharmaceuticals Announces Agreement with FDA on Resubmission of the Application for HETLIOZ for the Treatment of Patients with Smith-Magenis…

Page 35«..1020..34353637..4050..»